Scott E. James
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 10
- CAR-T cell therapy research 10
-
- Lipid metabolism and biosynthesis 1
- Eicosanoids and Hypertension Pharmacology 1
- Co-authors
- Oliver W. Press (5 shared papers)Michael C. Jensen (5 shared papers)Philip D. Greenberg (5 shared papers)Brian G. Till (4 shared papers)Stephen J. Forman (4 shared papers)Jinjuan Wang (4 shared papers)Andrew Antony Raubitschek (4 shared papers)Stanley R. Riddell (3 shared papers)
- Journals
- Blood (5 papers)The Journal of Immunology (2 papers)Human Gene Therapy (1 paper)Nature Medicine (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesNorwayAustralia
In The Last Decade
Scott E. James
12 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 51
- Oncology 1.2k
- Immunology 215
- Biochemistry 59
- Hematology 83
- Genetics 32
Countries citing papers authored by Scott E. James
This map shows the geographic impact of Scott E. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. James more than expected).
Fields of papers citing papers by Scott E. James
This network shows the impact of papers produced by Scott E. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. James. The network helps show where Scott E. James may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott E. James, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 612 | |
| 2 | 2008 | 212 | |
| 3 | 2017 | 190 | |
| 4 | 2007 | 185 | |
| 5 | 2004 | 134 | |
| 6 | 2018 | 72 | |
| 7 | 2009 | 53 | |
| 8 | 2010 | 25 | |
| 9 | 2024 | 24 | |
| 10 | 2021 | 22 | |
| 11 | 2024 | 7 | |
| 12 | 2016 | 1 |
About Scott E. James
Scott E. James is a scholar working on Oncology, Biochemistry, Pharmacology, Immunology and Nuclear Energy and Engineering, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Lipid metabolism and biosynthesis (1 paper), Inflammatory mediators and NSAID effects (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (1.2k citations), Immunology (215 citations), Biochemistry (59 citations), Hematology (83 citations) and Genetics (32 citations). Scott E. James has collaborated with scholars based in United States, Norway and Australia. Frequent co-authors include Oliver W. Press, Michael C. Jensen, Philip D. Greenberg, Brian G. Till, Stephen J. Forman, Jinjuan Wang, Andrew Antony Raubitschek, Stanley R. Riddell, Catherine G. Lindgren and Yukang Lin. Their work appears in journals such as Blood, The Journal of Immunology, Human Gene Therapy, Nature Medicine and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.